Search - tctmd.com

Displaying 161 - 173 of 173

Sort: Relevancy | Date

News Conference News ACC 2012

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

L.A. McKeown

March 25, 2012

News Conference News ACC 2012

BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy

Jason Kahn

March 25, 2012

News Conference News ACC 2012

Adjunctive Cilostazol Noninferior to Double-Dose Clopidogrel in All-Comer PCI Trial

L.A. McKeown

March 25, 2012

News Conference News ACC 2012

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Jason Kahn

March 24, 2012

Presentation ACC 2012

RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel

Presenter: Gennaro Sardella

March 24, 2012

News Conference News ACC 2012

Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel

Jason Kahn

March 24, 2012

News Conference News ACC 2012

Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation

March 24, 2012

Presentation ACC 2012

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 24, 2012

Video

» Interview

Beyond the Data: ACS/PCI Updates

April 3, 2022

Video

» Interview

TALOS-AMI: Clopidogrel vs Ticagrelor in Stabilized Patients After PCI for Acute MI

June 11, 2021

Video

» Interview

Sex-Specific Outcomes in TWILIGHT: Ticagrelor With or Without Aspirin After PCI

May 24, 2021

Video

» Interview

HOST-EXAM: Aspirin vs Clopidogrel During Chronic Maintenance Monotherapy After PCI

May 20, 2021

Video

» Interview

ACC 2019: The DEFINE PCI Trial: Blinded Physiologic Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention

March 18, 2019

Advertisement

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy

Adjunctive Cilostazol Noninferior to Double-Dose Clopidogrel in All-Comer PCI Trial

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel

Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel

Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation

Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial

Beyond the Data: ACS/PCI Updates

TALOS-AMI: Clopidogrel vs Ticagrelor in Stabilized Patients After PCI for Acute MI

Sex-Specific Outcomes in TWILIGHT: Ticagrelor With or Without Aspirin After PCI

HOST-EXAM: Aspirin vs Clopidogrel During Chronic Maintenance Monotherapy After PCI

ACC 2019: The DEFINE PCI Trial: Blinded Physiologic Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content